Figure 3: Reasons for using subcutaneous intermittent apomorphine injections in patients with Parkinson’s disease
| Close | |
|
|
|
|
Figure 3: Reasons for using subcutaneous intermittent apomorphine injections in patients with Parkinson’s disease
|
|